Principal
Chicago, IL
ajachak@rhprisk.com
T: +1 (678) 896-6042

Ashish Jachak, PhD

Dr. Ashish Jachak has over 15 years of experience in exposure science, risk assessment and management, consumer and product safety, and aerosol science. He has extensive experience in leading and managing cross functional teams using the risk management framework to guide and optimize product development for consumer goods from research and development to scale up, registration, and manufacturing. Dr. Jachak has assessed the application feasibility of exposure and toxicology models to solve complex problems in risk sciences and provide sound, unbiased and ethical solutions. He has collaborated and led integrated teams in toxicology, exposure sciences, industrial hygiene, environmental Sciences, product stewardship, regulatory affairs, and manufacturing to provide scientifically sound solutions for business lines which included oxygenated solvents, polymers and plastics, glycol ethers, EO/EG, PO/PG, and PEG in downstream uses such as consumer goods, pharmaceuticals, agricultural applications, electronics, and construction. In recent roles, he has been integral in the review of science based regulatory frameworks using partnerships with internal and external stakeholders to direct legislative actions based on scientifically sound and defensible exposure science and hazard data.

Dr. Jachak received his bachelor’s in chemical engineering from The Georgia Institute of Technology, Masters from the University of Michigan – Ann Arbor and Doctorate from the Johns Hopkins University – Bloomberg School of Public Health. His doctoral work involved modeling the migration, fate and transport of nanomaterials in the human lung and investigation of the biophysical interactions between cells of the human airways and nanomaterials. At his post-doctoral tenure at Brown University, Dr. Jachak performed quantitative modeling of the interactions between graphene-based nanomaterials and human lung and designed the synthesis of novel drug carriers for pharmaceutical applications. He also has a very strong interest in the field of computational fluid dynamics in applications ranging from transport and deposition of aerosols in the human lung to the optimization of filtration systems to reduce aerosol contaminants. More recently, he has completed an MBA from Imperial College – London and seeks to apply his business acumen in developing safe and sustainable solutions for the chemicals, petrochemicals, and consumer goods companies by guiding R&D organizations in accomplishing their strategic objectives.